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Abstract 
Bone cement prepared from polymethylmethacrylate (PMMA) powder and methylmethacrylate 
(MMA) liquid has been successfully demonstrated as one kind of artificial material to anchor 
joint replacements in bone. However, the cement itself lacks the capability to bond directly to 
living bone, so long-term implantation leads to an increased risk of loosening. It has been found 
that bioactive materials show better performance in fixation to bone, and the chemical bonding 
depends on bone-like apatite formation. This is triggered by surface reactions of biomaterials and 
body fluid. For these reactions, superficial functional groups like silanol (Si-OH) are ideal sites 
to induce apatite nucleation and the release of Ca2+ ions accelerates the apatite growth. Therefore, 
incorporation of materials containing these key components may provide the cement with 
apatite-forming ability. In this study, phosphoric acid 2-hydroxyethyl methacrylate ester 
(Pa2hme) or bis[2-(methacryloyloxy)ethyl] phosphate (BisP) supplying a phosphate group 
(PO4H2) was added into MMA liquid, while calcium acetate as a source of Ca
2+ ions was mixed 
into PMMA powder. The possibility of developing a bioactive PMMA bone cement using 
combinations of various amounts of calcium acetate and phosphate group-containing monomers 
was examined. The influences of the combinations on the setting time and compressive strength 
were also investigated. An apatite layer was observed on the cements modified with 30 mass% of 
P2ahme or BisP. The induction period was shortened with increased amounts of Ca(CH3COO)2. 
The setting time could be controlled by the Ca(CH3COO)2/monomer mass ratio. Faster setting 
was achieved at a ratio close to the mixing ratio of the powder/liquid (2:1), and both increases 
and decreases in the amount of Ca(CH3COO)2 prolonged the setting time based on this ratio. The 
highest compressive strength was 88.8±2.6 MPa, which exceeded the lower limit of ISO 5833 
but was lower than that of the SBF-soaked reference. The increase of additives caused the 
decline in compressive strength. In view of balancing apatite formation and clinical standard ISO 
5833, BisP is more suitable as an additive for bioactive PMMA bone cement, and the optimal 
modification is a combination of 30 mass% of BisP and 20 mass% of Ca(CH3COO)2.  
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Introduction 
As one kind of clinical material used for anchoring artificial hip joints to contiguous bone, 
polymethylmethacrylate (PMMA) bone cement has been paid much attention in the orthopedic 
field because of its better performance at the early recovery stage [1]. However, one significant 
problem is that PMMA cement lacks chemical bonding ability to bone. Intrinsic mechanical 
interlocking [2] is insufficient to sustain long-term stable implantation, so loosening between the 
cement and the implant is liable to occur.  
It is essential to develop a biocompatible and adhesive PMMA bone cement for 
implantation without loosening. Some bioactive materials such as bioglass 45S5 [3, 4] and glass-
ceramic A-W [5, 6] can generate a physiologically active bone-like apatite that creates a tight 
contact with living bone when implanted into the body environment. Incorporating such fillers 
into PMMA cement by mechanical mixing has also achieved the purpose of improved bone 
bonding [7], but this method still faces challenges in its details. For example, the formation of 
apatite was restricted to spots where the bioactive particles could be exposed to body fluid, and 
acquiring a better performance for affinity and osteoconductivity required an increase in the 
content of glass bead filler to 70 wt% [8]. The addition of massive amounts of bioactive powder 
may limit the physical properties of PMMA cement. Therefore, an alternative design for the 
fabrication of bioactive PMMA bone cement needs to be developed.  
It has been revealed that simulated body fluid (SBF), whose composition is nearly equal 
to that of human blood plasma [9], has a similar ability to body fluid for the production of bone 
mineral apatite [10]. Therefore, studies [11] related to the reaction mechanism between bioactive 
materials and SBF could be viewed as evidence to understand the formation process of apatite, 
and some functional groups such as Si-OH [12], -COOH [13], or PO4H2 [14] played an 
important role in attracting apatite nucleation while Ca2+ ions released into SBF accelerated the 
growth of apatite. These findings suggest that utilization of combinations of Si-OH groups and 
Ca2+ ions can possibly equip PMMA bone cement with apatite-forming ability. A previous study 
recommended calcium acetate as the ideal choice of calcium source, because of its appropriate 
solubility, satisfactory performance on setting time, and compressive strength among all calcium 
salts [15]. Tanahashi and Matsuda [14] discovered that the potentials of functional groups 
differed from one another in the aspect of inducing apatite nucleation. Because the nucleation 
rate decreased in the order of PO4H2 > -COOH >> -CONH2 ≈ -OH > -NH2, a phosphate group 
(PO4H2) was considered to be the optimal option [14]. It was reported that addition of 
phosphorylated hydroxyethylmethacrylate (HEMA-P) to the powder phase of PMMA cement 
promoted calcium phosphate mineralization in cell culture media, although improvement of 
SaOs-2 cell differentiation was not observed [16]. It is expected that addition of monomers with 
a phosphate group to the liquid phase would produce a cement with higher homogeneity. 
In the present study, two phosphate group-containing monomers, phosphoric acid 2-
hydroxyethyl methacrylate ester (Pa2hme) and Bis [2-(methacryloyloxy)ethyl] phosphate (BisP), 
were employed to supply a phosphate group (PO4H2), and their chemical structures were shown 
in Figure 1(a) and Figure 1(b), respectively. The primary aim was to develop a bioactive 
PMMA bone cement by modification with combinations of various amounts of calcium acetate 
and phosphate group-containing monomers, and the effects of these additives on the properties of 
the prepared cements were also investigated. Bioactivity was estimated by the apatite-forming 
ability in an SBF environment, and setting time and compressive strength were examined as 
workability and mechanical properties, respectively. The contents of calcium acetate and 
monomers were also optimized for practical application in clinical settings. 
 Materials and Methods 
All chemical regents used for the preparation and analyses in our study were of reagent 
grade without further purification. PMMA powders with a molecular weight about 70,000 and an 
average grain size of 4 µm were supplied by Sekisui Plastics Industries (Tokyo, Japan). Calcium 
acetate was produced by sintering calcium acetate monohydrate (Ca(CH3COO)2·H2O; Wako 
Chemical Industries, Osaka, Japan) at 220°C for 2 h and sieving to a particle size of <44 µm, 
followed by storage at 120°C before cement preparation. 
Cement preparation 
The sources for PMMA cement preparation were divided into two parts: powder source 
and liquid source. For the powder source, PMMA powders were mixed with pretreated 
Ca(CH3COO)2 powders combined with the polymerization initiator benzoyl peroxide (BPO; 
Wako Chemical Industries). For the liquid source, a mixture consisting of methylmethacrylate 
(MMA) liquid (Wako Chemical Industries), Pa2hme or BisP monomer (Aldrich, Tokyo, Japan), 
and N,N-dimethyl-p-toluidine (DmpT; Wako Chemical Industries) as a polymerization 
accelerator was used. The contents of the additives and the detailed compositions of the powder 
and liquid are shown in Table 1. The sample prepared with P00 and L00 (viewed as the 
reference) had the same composition as commercially available PMMA bone cement CMW® 1 
(DePuy International Ltd., Leeds, England). The mixing ratio of powder/liquid was 1:0.5 (g/g), 
and the whole preparation process was maintained at 23±2°C with a relative humidity of 
50±10%. 
Setting time tests 
A mixed paste of 5 g of cement was used for determination of the setting time. For this, a 
thermocouple probe (plamic 100 Ω) connected to a thermo recorder (TR-81; T&D Corp., 
Matsumoto, Japan) was installed into the center of the paste to test the curing temperature per 
second, until the temperature started to drop. The setting time was defined as the time 
corresponding to (Tmax+Tstart.)/2 (Tmax: maximum temperature; Tstart: temperature at start of 
setting) on the temperature/time curve according to ISO 5833 [17]. The tests were repeated four 
times for each combination. All of the setting times are presented as means ± SD.  
Bioactivity evaluation in SBF 
Bioactivity was evaluated by the formation of apatite on the cement surface in a 
simulated body environment. SBF (in mol m-3: Na+ 142.0, K+ 5.0, Mg2+ 1.5, Ca2+ 2.5, Cl- 147.8, 
HCO3
- 4.2, HPO4
2- 1.0, SO4
2- 0.5) was prepared by dissolving the initial reagents (NaCl, NaHCO3, 
KCl, K2HPO4·3H2O, MgCl2·6H2O, CaCl2, Na2SO4) in ultrapure water and buffering to pH 7.40 
with (CH2OH)3CNH2 and an appropriate amount of 1 M HCl solution. Further details of the SBF 
preparation were described in a previous report [10]. The cements were polished with #1000 SiC 
paper, cut into rectangular pieces with dimensions of 10×15×1 mm3, and stored in plastic 
containers filled with 35 mL of SBF at 37°C. After soaking for designated periods (1, 3, 7, and 
14 days), the cements were removed, rinsed, and dried at room temperature. A thin-film X-ray 
diffractometer (TF-XRD) (MXP3V; MAC Science Ltd., Yokohama, Japan) and scanning 
electron microscope (SEM) (S-3500N; Hitachi High-Technologies, Tokyo, Japan) were 
employed to investigate the surface changes in the structure and morphology of the SBF-soaked 
cements. The TF-XRD patterns were obtained using a step scanning mode at 0.02° steps per 
second with CuKα radiation. Before SEM observation, a thin film of carbon was sputter-coated 
on all specimens. A pH meter (F-23IIC; Horiba Ltd., Kyoto, Japan) was introduced to detect the 
pH values of the SBF used for bioactivity examinations after the designated periods. The 
concentrations of calcium (Ca) in SBF after the same periods were measured by inductively 
coupled plasma-optical emission spectrometry (ICP-OES) (Optima 4300 DV; PerkinElmer Inc., 
Waltham, MA). 
Mechanical measurement 
Cylindrical samples of 6 mm in diameter and 12 mm in height were utilized for 
compressive strength measurement. Samples of all specimens before complete hardening were 
immersed in SBF at 37°C for 7 days, and then subjected to a compressive load with a crosshead 
speed of 20 mm/min controlled by a Universal Testing Machine (Autograph AG-1; Shimadzu 
Co., Kyoto, Japan) until fracture occurred. The compressive strength was calculated by the 
fracture load and the sample’s cross-sectional area. The means and SDs were collected from ten 
specimens for each combination.  
  
RESULTS 
It was noted that P2ahme only dissolved well in the MMA liquid phase without 
separation beyond 30 mass%. In addition, the cements prepared with P2ahme50# and CA20% 
remained in a dough state after standing for 2 h. Therefore, these preparations were only 
subjected to bioactivity examination. 
Setting behavior 
Table 2 lists the setting times of all cements prepared with the combinations of calcium 
acetate and P2ahme or BisP under various contents. The combinations of Ca(CH3COO)2 and 
monomers led to accelerated setting compared with the reference sample. Comparisons among 
all the modified cements revealed that the P2ahme-based cements had longer setting times than 
the BisP-based cements when modified with the same content of Ca(CH3COO)2. Under the same 
content of both monomers, the samples with Ca(CH3COO)2/monomers mass ratios close to the 
powder/liquid mixing ratio (2:1) showed a tendency to exhibit a shorter setting time. Both 
increases and decreases in the amount of Ca(CH3COO)2 prolonged the setting time. 
Characterization of apatite formation 
Figure 2 shows SEM photographs of the surface morphologies of cements modified with 
the combinations of various contents of Ca(CH3COO)2 and monomers after soaking in SBF for 
14 days. Only scratches were observed on the surface of the reference sample. The other 
photographs shown in Figure 1(b), and (h) to (m) retained similar surface features to the 
reference sample, meaning that no precipitates were deposited on these cements. Meanwhile, the 
surfaces of the remaining samples were covered with a layer composed of homogeneous 
precipitated particles, and the individual particles were spherical.  
Figure 3 shows the TF-XRD patterns of the reference sample and the cements covered 
with a precipitated layer after soaking in SBF for various periods. The peaks with low 
crystallinity appearing at about 26°, 32°, and 34° in 2θ were assigned to the diffractions of 
apatite on the basis of JCPDS Card No. 09-0432. Therefore, the spherical deposits observed 
under the SEM were identified as low-crystallized apatite by comparison with the results for the 
reference sample.  
The apatite-forming ability of the cements with various contents of Ca(CH3COO)2 and 
monomers in SBF was judged by the TF-XRD results, and the evaluations are summarized in 
Table 3. The induction period varied from 1 to 14 days depending on the combinations of 
Ca(CH3COO)2 and monomers. The BisP-based cements exhibited better performances than the 
P2ahme-based cements. An increase in Ca(CH3COO)2 accelerated the formation rate of apatite, 
while increases in the monomers rather delayed the formation rate. 
Variation in compressive strength 
The compressive strength of the cements as a function of the contents of additives after 7 
days of soaking in SBF are summarized in Figure 4. The highest compressive strength was 
88.8±2.6 MPa, and still lower than that of the SBF-soaked reference (96.9±7.2 MPa). The 
cements prepared with Bis30# and CA20%, Bis30# and CA35%, and Bis50# and CA20% as 
well as P2ahme30# and CA20% exceeded the lower limit of ISO 5833 [17]. It was clearly seen 
that the compressive strength decreased with increases in the additives, and that P2ahme 
produced greater deterioration than BisP under the same Ca(CH3COO)2 content.  
Figure 5 shows the changes in the concentration of Ca2+ ions in SBF (Figure 5(a)) and 
the corresponding pH values of SBF measured at 37°C (Figure 5(b)) after various periods of 
cement immersion. The rapid release of Ca2+ ions was completed within 3 days of soaking for 
most of the specimens. As more Ca(CH3COO)2 was added to the cements, more Ca
2+ ions were 
released irrespective of the formation of apatite. The contents of both monomers had no 
significant influence on the Ca2+ ion release. Generally, hydrolysis of acetate ions (CH3COO
-) 
provides OH- to increase the pH. Therefore, it is assumed that the decrease in pH was induced by 
the release of acidic monomers or consumption of OH- during the apatite precipitation.  
 
Discussion 
The acceleration of cement setting observed in our study is consistent with the results for 
modification of PMMA cement with HEMA-P [16]. Considering the corresponding relationship 
between the shortest time and the mass ratio of Ca(CH3COO)2/monomer, it is assumed that the 
ionic phosphate-containing monomers and Ca2+ counteracted each other in the condition close to 
the powder/liquid mixing ratio. However, no regular variation could be found in the relationship 
of the setting time and the contents of both monomers, because a high content (50#) of 
monomers did not just prolong the setting, but damaged the radical polymerization reaction (as 
seen the specimen prepared with P2ahme50# and CA20%). 
Incorporation of Ca(CH3COO)2 and phosphate group-containing monomers provided the 
traditional PMMA bone cement with bioactivity in terms of apatite formation. In addition, the 
generation of a bioactive surface consisting of spherical apatite particles under SEM observation 
indicates that this concept successfully overcame the remaining drawback in the bioactivity 
modification by adopting bioactive glass bead fillers. Compared with combinations of calcium 
chloride (CaCl2) and methacryloxypropyltrimethoxysilane (MPS), the phosphate (PO4H2) in the 
structure of P2ahme or BisP shares the same role as the silane (Si-OH) [18]. Specifically, these 
sufficient functional groups are uniformly distributed on the cement surface and initiate 
heterogeneous nucleation of apatite, while continuous release of Ca2+ ions boosts its 
concentration in the surrounding environment, leading to an increasing supersaturation degree 
with respect to apatite, and thereby increasing the amount of Ca(CH3COO)2 to shorten the 
apatite-forming period of the modified cements. However, the increase in Ca(CH3COO)2 in the 
cement modified with 50 mass% of the monomers did not enhance the apatite-forming ability. A 
possible reason is that the condition produced by the pH of SBF combined with the ions (Ca2+ or 
PO4
3-) on the surface was not suitable for apatite precipitation (as seen in Figure 5 (a, b)). On the 
other hand, incorporation of Ca(CH3COO)2 and P2ahme or BisP was incapable of making up the 
loss of compressive strength from the replaced parts of the cements, and thus more additives led 
to greater deterioration in the mechanical strengths, while the continuous release of Ca2+ ions 
(seen in Figure 5. (a)) left pores in the modified cements, which caused further loss of strength 
after exposure to SBF [19]. Even if the pores in bioactive PMMA cements could be filled by 
apatite, tiny amounts of apatite were unable to sustain the strength of the cements.  
Consequently, BisP was more suitable than P2ahme as a modifier for PMMA bone 
cement, and the optimized modification to satisfy practical standard ISO 5833 was obtained by 
addition of 30 mass% of BisP and 20 mass% of Ca(CH3COO)2, when the bioactivity and 
mechanical properties in this study were taken into consideration. Although the setting time of 
this optimal modified cement just passed the lower limit of ISO 5833, the monomer BisP is 
unlike P2ahme, and still has the potential for lowering of its content in the liquid phase, which 
means that not only the setting time, but also the mechanical strength in a balance with the 
bioactivity can be further improved by choosing appropriate combinations of both additives. 
Deeper optimization related to the contents of Ca(CH3COO)2 and BisP should be investigated in 
a future study. 
 
CONCLUSIONS 
Modification with Ca(CH3COO)2 and a phosphate group-containing monomer (P2ahme 
or BisP) can equip PMMA bone cement with apatite-forming ability in simulated body 
environment, which is expected to bring a higher potential of bone bonding once implanted into 
body. The monomer BisP showed better performance than Pa2hme on the apatite-forming ability 
and mechanical strength of the cement. Increasing the content of Ca(CH3COO)2 significantly 
shortened the formation period of the bioactive layer, while high ratios of all additives in 
modified cements resulted in deterioration of the compressive strength. Incorporation of 30 mass% 
of BisP and 20 mass% of Ca(CH3COO)2 was identified as the optimized modification with a 
view to a balance of bioactivity and practical standard ISO 5833. The combinations of 
Ca(CH3COO)2 and phosphate group-containing monomers expand the feasibility for the design 
of bioactive bone cements for orthopedic use. 
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Table 1. Detailed constituents of the powder and liquid phases 
 
CA: heat-treated Ca(CH3COO)2. XX: phosphate group-containing monomer (Pa2hme or BisP). 
  
CA 
CAPMMA + CA powder (mass ratio)  XX XXMMA+ XX liquid (mass ratio) PMMA CA BPO  MMA XX DmpT 
P00 0.00 0.971 0 0.029  L00 0.00 0.496 0 0.004 
20% 0.20 0.777 0.194 0.029  
30# 0.30 0.347 0.149 0.004 
35% 0.35 0.631 0.340 0.029  
50% 0.50 0.486 0.485 0.029  50# 0.50 0.248 0.248 0.004 
 
 
Table 2. Setting times for the cements containing various contents of Ca(CH3COO)2 and monomers 
 
 
 
 
 
 
Reference: 361±25 s. 
∞: No heat release was detected; viewed as an unset cement. 
  
Cement composition 
Setting time (s) 
CA20% CA35% CA50% 
Pa2hme30# 215 ± 18 183 ± 16 200 ± 7 
Bis30# 185 ± 8 159 ± 3 168 ± 8 
Pa2hme50# ∞ 247 ± 6 192 ± 17 
Bis50# 210 ± 10 135 ± 7 120 ± 10 
 
 
Table 3. Apatite-forming ability of PMMA cements modified with combinations of various amounts of 
Ca(CH3COO)2 and monomers (P2ahme or BisP) in the SBF environment, based on the TF-XRD results
# 
of designated soaking periods 
 
 
 
 
 
 
#–: No apatite found after 14 days; +: apatite formed within 14 days; ++: apatite formed within 3 days; 
+++: apatite formed within 1 day. 
  
Cement 
composition 
apatite-forming period (d) 
CA20% CA35% CA50% 
Pa2hme30# – + ++ 
BisP30# + ++ +++ 
Pa2hme50# – – – 
BisP50# – – – 
  
 
 
 
 
 
 
 
Figure 1. (a, b) Chemical structures of phosphoric acid 2-hydroxyethyl methacrylate ester (a) 
and Bis [2-(methacryloyloxy)ethyl] phosphate (b) 
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Figure 2. SEM photographs of the surfaces of cements modified with the combinations of 
various amounts of Ca(CH3COO)2 and P2ahme or BisP after soaking in SBF for 14 days. 
  
(b) Pa2hme30# + CA20% (c) Pa2hme30# + CA35% (d) Pa2hme30# + CA50% 
(e) BisP 30# + CA 20% (f) BisP 30# + CA 35% (g) BisP 30# + CA 50% 
(h) Pa2hme50# + CA20% (i) Pa2hme50# + CA35% (j) Pa2hme50# + CA50% 
(m) BisP50# + CA50% (k) BisP50# + CA20% (l) BisP50# + CA35% 
(a) Reference 
Figure 3. TF-XRD patterns of the surfaces of the cements prepared with (a) P00 and L00, (b)
Pa2hme30# and CA35%, (c) Pa2hme30# and CA50%, (d) BisP30# and CA20%, (e) BisP30#
and+ CA35%, and (f) BisP30# and CA50% before (0 d) and after soaking in SBF for the 
designated periods. Black circles ( ): apatite.
Figure 4. Variations in compressive strength of the cements as a function of the contents of 
Ca(CH3COO)2 and monomers after soaking in SBF for 7 days.
Figure 5. (a, b) Concentrations of Ca2+ ions in SBF (a) and pH values of SBF measured at 37°C
(b) after soaking the modified cements for the designated periods.
(a) 
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